Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)
No Thumbnail Available
Issue Date
2022
Our author(s)
Marta, M.
Department
Keywords
Language
English
Publisher
Elsevier
ISSN
2211-0348
2211-0356
2211-0356
eISSN
ISBN
Type
Article
Citation
Dobson, R., Craner, M., Waddingham, E., Miller, A., Pindoria, J., Cavey, A., Blain, C., De Luca, G., Evangelou, N., Ford, H., Gallagher, P., George, K., Geraldes Ramos Dias, R., Harman, P., Hobart, J., King, T., Linighan, R., Macdougall, N., Marta, M., Mitchell, S., Nicholas, R., Rog, D., Scalfari, A., Scolding, N., Webb, S., White, S., Wilton, J., Young, C. & Matthews, P. M. 2022. Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS). Multiple Sclerosis and Related Disorders, 63, 103894.